SERUM LIFE SCIENCES LIMITED — Vaccine Importer Profile
Pharmaceutical Importer · #7 buyer for Vaccine · $2.3M import value · 51 shipments · UNITED STATES · DGFT Verified
SERUM LIFE SCIENCES LIMITED is the #7 importer of Vaccine from India with $2.3M in import value and 51 verified shipments. SERUM LIFE SCIENCES LIMITED holds a 0.4% market share in Vaccine imports based in UNITED STATES. The company sources from 1 verified supplier across 5 formulations shipped to 22 countries.
SERUM LIFE SCIENCES LIMITED — Vaccine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Vaccine to SERUM LIFE SCIENCES LIMITED?
Verified from 51 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SERUM INSTITUTE OF INDIA PRIVATE LIMITED | $2.3M | 51 | 100.0% |
SERUM LIFE SCIENCES LIMITED sources Vaccine from 1 verified Indian supplier based on 51 customs records. The primary supplier is SERUM INSTITUTE OF INDIA PRIVATE LIMITED accounting for 100.0% of imports.
How Does SERUM LIFE SCIENCES LIMITED Compare to Nearest Vaccine Importers?
Buyers ranked immediately above and below #7 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | SERUM LIFE SCIENCES LTD | IRELAND | $1.4M | 27 | $50.0K |
| 6 | XXRUMXXIFEXXCIEXXES XXD | SUDAN | $1.2M | 24 | $50.0K |
| 7 | SERUM LIFE SCIENCES LIMITED ★ | SUDAN | $1.2M | 24 | $50.0K |
SERUM LIFE SCIENCES LIMITED ranks #7 among 2,202 Vaccine importers from India. Average shipment value of $50.0K compared to the market average of $17.3K. The closest competitors by value are SERUM LIFE SCIENCES LTD and XXRUMXXIFEXXCIEXXES XXD.
Where Does SERUM LIFE SCIENCES LIMITED Import Vaccine To?
Destination countries from 51 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $900.0K | 18 | 39.7% |
| IRELAND | $150.0K | 3 | 6.6% |
| ETHIOPIA | $150.0K | 3 | 6.6% |
| NEPAL | $150.0K | 3 | 6.6% |
| NIGERIA | $150.0K | 3 | 6.6% |
| YEMEN | $150.0K | 3 | 6.6% |
| NETHERLANDS | $100.0K | 2 | 4.4% |
| IVORY COAST | $50.0K | 1 | 2.2% |
| MALAWI | $50.0K | 1 | 2.2% |
| KENYA | $50.0K | 1 | 2.2% |
SERUM LIFE SCIENCES LIMITED imports Vaccine to 22 countries. The primary destination is UNITED STATES receiving 39.7% of shipments worth $900.0K.
What Vaccine Formulations Does SERUM LIFE SCIENCES LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| OTHER MIX VACCINE-LIQUID VACCINE- | $1.1M | 25 |
| NUVAXOVID COVID-19 VACCINE | $650.0K | 13 |
| NUVAXOVID COVID-19 VACCINE | $450.0K | 9 |
| VACCINE FOR HUMAN MEDICINE NUVAXOVID | $50.0K | 1 |
| MIXED VACCINE FOR DPT-LIQUID- | $43.6K | 3 |
SERUM LIFE SCIENCES LIMITED imports 5 distinct Vaccine formulations from India. The top formulation is OTHER MIX VACCINE-LIQUID VACCINE- with 25 shipments worth $1.1M.
Regulatory Requirements: Importing Vaccine into United States
What SERUM LIFE SCIENCES LIMITED and other importers must comply with to import Vaccine from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Vaccine
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Vaccine from India and How Much Does SERUM LIFE SCIENCES LIMITED Import?
India exported $38.1M worth of Vaccine through 14,355 shipments from 325 suppliers to 192 countries, serving 2,202 buyers globally. SERUM LIFE SCIENCES LIMITED imports $2.3M of this total, accounting for 0.4% of India's Vaccine exports with 51 shipments from UNITED STATES. This is verified from 51 customs shipment records covering 5 distinct formulations.
What Is the Average Order Value for SERUM LIFE SCIENCES LIMITED's Vaccine Imports?
SERUM LIFE SCIENCES LIMITED's average Vaccine order value is $44.5K per consignment, based on 51 shipments totaling $2.3M. SERUM LIFE SCIENCES LIMITED is based in UNITED STATES and ranks #7 among all Vaccine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Vaccine to SERUM LIFE SCIENCES LIMITED?
SERUM LIFE SCIENCES LIMITED sources Vaccine from 1 verified Indian supplier: SERUM INSTITUTE OF INDIA PRIVATE LIMITED ($2.3M, 100.0%). This is based on 51 customs records.
How Does SERUM LIFE SCIENCES LIMITED Compare to Other Vaccine Importers?
SERUM LIFE SCIENCES LIMITED ranks #7 among 2,202 Vaccine importers from India with a 0.4% market share. The top 3 importers are NATIONAL PRIMARY HEALTH CARE ($6.3M), UNICEF SUPPLY DIVISION ($5.0M), MINISTRY OF HEALTH ($4.5M). SERUM LIFE SCIENCES LIMITED processed 51 shipments from UNITED STATES.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vaccine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: SERUM LIFE SCIENCES LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as SERUM LIFE SCIENCES LIMITED's capped import value divided by total capped export value for Vaccine across all Indian exporters.
- 5.Verified Records: This page is backed by 51 individual customs records matching SERUM LIFE SCIENCES LIMITED importing Vaccine, covering 5 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 192+ countries, 2,202+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vaccine Import Data for SERUM LIFE SCIENCES LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for SERUM LIFE SCIENCES LIMITED's Vaccine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SERUM LIFE SCIENCES LIMITED
Company Profile
Multiple products · $0 total trade · Multiple categories
SERUM LIFE SCIENCES LIMITED × Vaccine
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for SERUM LIFE SCIENCES LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vaccine. For current order-level data, contact TransData Nexus.